bibliographic entry 12414301 [be/12414301]
https://w3id.org/oc/corpus/be/12414301

is a
content
  • Kristensen, G, Harter, P, Trédan, O, Sailer, M. O, Bamias, A, Colombo, N, … Bois, A. D. (2014). Independent review of AGO-OVAR 12, a GCIG/ENGOT-Intergroup phase III trial of nintedanib (N) in first-line therapy for ovarian cancer (OC). Journal of Clinical Oncology, 32:5s(suppl; abstr 5556^). Retrieved from http://meetinglibrary.asco.org/content/130341-144.
references